Acting US FDA Chief Sharpless Pledges "Full Speed Ahead" On Agency's Current Agenda

In his first speech to agency staff, Acting Commissioner Norman Sharpless says FDA will continue working on issues including drug pricing and opioids – and he is not approaching the post like a temporary caretaker. 

FDAEntrance_1200x675

Newly installed US FDA Acting Commissioner Norman Sharpless plans to continue vigorous progress on the policy agenda initiated under his predecessor Scott Gottlieb. And while he now serves on an acting basis – pending the White House nomination and Senate confirmation of a new commissioner – Sharpless has made clear he will not approach the top post like a temporary fill-in.

In his first FDA-wide speech, Sharpless said his appointment does not reflect an attempt by President Trump or Department of...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership